zirconium has been researched along with monomethyl auristatin e in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Firestein, R; Flores, JE; Gill, HS; Go, M; Goldsmith, J; Kan, D; Lau, J; Mao, W; Marik, J; Miao, L; Ogasawara, A; Rubinfeld, B; Terwisscha van Scheltinga, AG; Tinianow, JN; Vanderbilt, AN; Williams, SP; Yu, SF | 1 |
1 other study(ies) available for zirconium and monomethyl auristatin e
Article | Year |
---|---|
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Humans; Immunoconjugates; Male; Membrane Proteins; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Oligopeptides; Oxidoreductases; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Xenograft Model Antitumor Assays; Zirconium | 2016 |